Search research articles
Contact Us
Filters
Showing results (1-10 of 143) with videos related to
Page
of 15
Sort By:
The Journal of Rheumatology
|
February 4, 2014
Belimumab in systemic lupus erythematosus -- what can be learned from longterm observational studies?
Anders A Bengtsson
Rheumatology (Oxford, England)
|
June 13, 2017
Comment on: Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus: reply
Christian Lood, Anders A Bengtsson
Immunological Investigations
|
February 27, 2008
Presence of IgG-CD4 complexes in the circulation
Roald Nezlin, Anders A Bengtsson
Best Practice & Research. Clinical Rheumatology
|
December 12, 2017
Role of interferons in SLE
Anders A Bengtsson, Lars Rönnblom
Arthritis Research & Therapy
|
May 31, 2020
Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
Anders A Bengtsson, Helena Tyden, Christian Lood
Autoimmunity
|
December 14, 2007
Complement deficiencies and systemic lupus erythematosus
Lennart Truedsson, Anders A Bengtsson, Gunnar Sturfelt
The Journal of Rheumatology
|
November 13, 2008
Improved lupus outcome. We are doing a good job, but could we do better?
Ola Nived, Gunnar Sturfelt, Anders A Bengtsson
Annals of the Rheumatic Diseases
|
May 22, 2014
The complement system in systemic lupus erythematosus: an update
Jonatan Leffler, Anders A Bengtsson, Anna M Blom
Arthritis Research & Therapy
|
April 3, 2004
Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
Christopher Sjöwall, Anders A Bengtsson, Gunnar Sturfelt, et al.
Clinical Immunology (Orlando, Fla.)
|
November 27, 2007
SLE serum induces classical caspase-dependent apoptosis independent of death receptors
Anders A Bengtsson, Birgitta Gullstrand, Lennart Truedsson, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 143) with videos related to
Sort By:
Page
of 15
The Journal of Rheumatology
|
February 4, 2014
Belimumab in systemic lupus erythematosus -- what can be learned from longterm observational studies?
Anders A Bengtsson
Rheumatology (Oxford, England)
|
June 13, 2017
Comment on: Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus: reply
Christian Lood, Anders A Bengtsson
Immunological Investigations
|
February 27, 2008
Presence of IgG-CD4 complexes in the circulation
Roald Nezlin, Anders A Bengtsson
Best Practice & Research. Clinical Rheumatology
|
December 12, 2017
Role of interferons in SLE
Anders A Bengtsson, Lars Rönnblom
Arthritis Research & Therapy
|
May 31, 2020
Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
Anders A Bengtsson, Helena Tyden, Christian Lood
Autoimmunity
|
December 14, 2007
Complement deficiencies and systemic lupus erythematosus
Lennart Truedsson, Anders A Bengtsson, Gunnar Sturfelt
The Journal of Rheumatology
|
November 13, 2008
Improved lupus outcome. We are doing a good job, but could we do better?
Ola Nived, Gunnar Sturfelt, Anders A Bengtsson
Annals of the Rheumatic Diseases
|
May 22, 2014
The complement system in systemic lupus erythematosus: an update
Jonatan Leffler, Anders A Bengtsson, Anna M Blom
Arthritis Research & Therapy
|
April 3, 2004
Serum levels of autoantibodies against monomeric C-reactive protein are correlated with disease activity in systemic lupus erythematosus
Christopher Sjöwall, Anders A Bengtsson, Gunnar Sturfelt, et al.
Clinical Immunology (Orlando, Fla.)
|
November 27, 2007
SLE serum induces classical caspase-dependent apoptosis independent of death receptors
Anders A Bengtsson, Birgitta Gullstrand, Lennart Truedsson, et al.
Page
of 15